QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hess, L. M Articles by Malone, D. C Search for Related Content PubMed PubMed Citation Articles by Hess, L. M Articles by Malone, D. C

ADHERENCE

Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures

Science Officer, Arizona Cancer Center, University of Arizona, Tucson, AZ

Marsha A Raebel, PharmD

Pharmacotherapy Research Manager, Kaiser Permanente of Colorado, Denver, CO; Clinical Associate Professor, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver

Douglas A Conner, PhD

Senior Research Analyst, Kaiser Permanente of Colorado

Daniel C Malone, PhD

Associate Professor, College of Pharmacy, University of Arizona

Reprints: Ms. Hess, Arizona Cancer Center, 1515 N. Campbell Ave., PO Box 245024, Tucson, AZ 85724-5024, fax 520/626-5350, hess{at}u.arizona.edu

BACKGROUND: A variety of measures have been developed to calculate refill adherence from administrative data such as pharmacy claims databases. These measures have focused on improving the accuracy of adherence measures or clarifying the evaluation time frame. As a result, there are many measures used to assess adherence that may or may not be comparable or accurate.

OBJECTIVE: To compare available refill adherence measures.

METHODS: A systematic literature review was conducted to identify current or recently used measures of calculating adherence from administrative data. A MEDLINE search (January 1990-March 2006) was undertaken using the search terms adherence or compliance in the title combined with administrative, pharmacy, or records in any field, including subheadings medical, nursing, and hospital records. Non-English articles were excluded. Seven hundred fifteen articles were available for review. Review articles and letters were excluded from measure selection, but were included in the search terms and used to identify additional research articles. Adherence measures were excluded if they were incompletely described, produced non-numeric values, or were duplicates. Eleven refill adherence measures were identified and compared using data from the LOSE Weight (Long-term Outcomes of Sibutramine Effectiveness on Weight) study. Measures compared include Continuous Measure of Medication Acquisition (CMA); Continuous Multiple Interval Measure of Oversupply (CMOS); Medication Possession Ratio (MPR); Medication Refill Adherence (MRA); Continuous Measure of Medication Gaps (CMG); Continuous, Single Interval Measure of Medication Aquisition (CSA); Proportion of Days Covered (PDC); Refill Compliance Rate (RCR); Medication Possession Ratio, modified (MPRm); Dates Between Fills Adherence Rate (DBR); and Compliance Rate (CR).

RESULTS: The results suggest that the CMA, CMOS, MPR, and MRA are identical in terms of measuring adherence to prescription refills throughout the study period, each with a value of 63.5%; CMG and PDC are slightly lower (63.0%) and are equivalent to MRA when oversupply is truncated. CR, MPRm, RCR, and CSA result in higher adherence values of 84.4%, 86.6%, 104.8%, and 109.7%, respectively.

CONCLUSIONS: Five measures produce equivalent results for measuring prescription refill adherence over the evaluation period. Of these, MRA has the fewest calculations, is easily truncated if one desires to exclude surplus medication issues, and requires the least amount of data. MRA is therefore recommended as the preferred measure of adherence using administrative data.

Key Words: adherence, administrative data, compliance, measurement

Published Online, July 25, 2006. www.theannals.com, DOI 10.1345/aph.1H018

This article has been cited by other articles:

				R. J. Mullan, V. M. Montori, N. D. Shah, T. J. H. Christianson, S. C. Bryant, G. H. Guyatt, L. I. Perestelo-Perez, R. J. Stroebel, B. P. Yawn, V. Yapuncich, et al. The Diabetes Mellitus Medication Choice Decision Aid: A Randomized Trial Arch Intern Med, September 28, 2009; 169(17): 1560 - 1568. [Abstract] [Full Text] [PDF]

				J. F. Steiner, P. M. Ho, B. L. Beaty, L. M. Dickinson, R. Hanratty, C. Zeng, H. M. Tavel, E. P. Havranek, A. J. Davidson, D. J. Magid, et al. Sociodemographic and Clinical Characteristics Are Not Clinically Useful Predictors of Refill Adherence in Patients With Hypertension Circ Cardiovasc Qual Outcomes, September 1, 2009; 2(5): 451 - 457. [Abstract] [Full Text] [PDF]

				J. E. Lafata, E. A. Dobie, G. W. Divine, M. E. Ulcickas Yood, and B. D. McCarthy Sustained Hyperglycemia Among Patients With Diabetes: What matters when action is needed? Diabetes Care, August 1, 2009; 32(8): 1447 - 1452. [Abstract] [Full Text] [PDF]

				P. M. Ho, C. L. Bryson, and J. S. Rumsfeld Medication Adherence: Its Importance in Cardiovascular Outcomes Circulation, June 16, 2009; 119(23): 3028 - 3035. [Abstract] [Full Text] [PDF]

				D. A. Lamb, D. T. Eurich, F. A. McAlister, R. T. Tsuyuki, W. M. Semchuk, T. W. Wilson, and D. F. Blackburn Changes in Adherence to Evidence-Based Medications in the First Year After Initial Hospitalization for Heart Failure: Observational Cohort Study From 1994 to 2003 Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 228 - 235. [Abstract] [Full Text] [PDF]

				I. Poon, L. S Lal, M. E Ford, and U. K Braun Racial/Ethnic Disparities in Medication Use Among Veterans with Hypertension and Dementia: A National Cohort Study Ann. Pharmacother., February 1, 2009; 43(2): 185 - 193. [Abstract] [Full Text] [PDF]

				B. C Martin, E. K Wiley-Exley, S. Richards, M. E Domino, T. S Carey, and B. L. Sleath Contrasting Measures of Adherence with Simple Drug Use, Medication Switching, and Therapeutic Duplication Ann. Pharmacother., January 1, 2009; 43(1): 36 - 44. [Abstract] [Full Text] [PDF]

				F.-Z. Kettani, A. Dragomir, R. Cote, L. Roy, A. Berard, L. Blais, L. Lalonde, P. Moreau, and S. Perreault Impact of a Better Adherence to Antihypertensive Agents on Cerebrovascular Disease for Primary Prevention Stroke, January 1, 2009; 40(1): 213 - 220. [Abstract] [Full Text] [PDF]

				M. A. Chisholm-Burns and C. A. Spivey Pharmacoadherence: A new term for a significant problem Am. J. Health Syst. Pharm., April 1, 2008; 65(7): 661 - 667. [Full Text] [PDF]

				E. Mehuys, L. Van Bortel, L. De Bolle, I. Van Tongelen, L. Annemans, J. P. Remon, and G. Brusselle Effectiveness of pharmacist intervention for asthma control improvement Eur. Respir. J., April 1, 2008; 31(4): 790 - 799. [Abstract] [Full Text] [PDF]

				D. S. Friedman, H. A. Quigley, L. Gelb, J. Tan, J. Margolis, S. N. Shah, E. E. Kim, T. Zimmerman, and S. R. Hahn Using Pharmacy Claims Data to Study Adherence to Glaucoma Medications: Methodology and Findings of the Glaucoma Adherence and Persistency Study (GAPS) Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5052 - 5057. [Abstract] [Full Text] [PDF]

				D. P Nau, D. T Steinke, L K. Williams, R. Austin, J. E. Lafata, G. Divine, and M. Pladevall Adherence Analysis Using Visual Analog Scale Versus Claims-Based Estimation Ann. Pharmacother., November 1, 2007; 41(11): 1792 - 1797. [Abstract] [Full Text] [PDF]